RxDoctor Payments Data

Ricardo Perez, MD

Family Medicine · Bayamon, PRNPI 1144280108

Payments from drug & device makers

$1,226in general payments, 2019–2025

Across 31 payments — averaging $39.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$351
  • Boston Scientific$247
  • Johnson & Johnson$229
  • AstraZeneca$124
  • GSK$90
  • Merck$73
  • plus $113 from 4 others

What the payments were for

  • Food & beverage$1,226100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie4$351
Boston Scientific7$247
Johnson & Johnson4$229
AstraZeneca7$124
GSK1$90
Merck3$73
PBG Puerto Rico LLC2$40
Boehringer Ingelheim1$32
Sanofi-aventis U.S. LLC1$25
Medtronic1$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,226 in reported general payments places this provider in the 80th percentile of 497 family medicine providers in Puerto Rico.

See all family medicine providers in Puerto Rico

Medicare billing

Part B allowed, 2024
$8,184
Medicare patients
41
Services billed
99

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin76$120,340
TrulicityDulaglutide54$68,148
Trijardy XrEmpaglifloz/Linaglip/Metformin50$67,649
SynthroidLevothyroxine Sodium320$39,967
GlyxambiEmpagliflozin/Linagliptin21$35,419
JanuviaSitagliptin Phosphate25$34,686
EliquisApixaban23$33,610
FarxigaDapagliflozin Propanediol17$24,578
XareltoRivaroxaban21$22,379
Synjardy XrEmpagliflozin/Metformin Hcl17$20,846
JanumetSitagliptin Phos/Metformin Hcl14$17,233
TradjentaLinagliptin11$15,770
SynjardyEmpagliflozin/Metformin Hcl13$11,627
LantusInsulin Glargine,hum.Rec.Anlog48$7,487
Losartan Potassium459$7,157

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Trijardy Xr, Glyxambi, Synjardy Xr, Tradjenta$32$271,651188 claims
MerckJanuvia, Janumet$73$51,91939 claims
AbbVieSynthroid$351$39,967320 claims
AstraZenecaFarxiga$124$24,57817 claims
Johnson & JohnsonXarelto$229$22,37921 claims
Sanofi-aventis U.S. LLCLantus$25$7,48748 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 497 family medicine providers in Puerto Rico.

Other family medicine in Bayamon

See the full list for Puerto Rico

Where these figures come from

Is this you, or does something look wrong? →